RORINE INTERNATIONAL HOLDING (RIHC) 10-K 9 May 17 2016 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Nov. 30, 2016	May 02, 2017	May 31, 2016
Document and Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Nov. 30, 2016
Entity Registrant Name	RORINE INTERNATIONAL HOLDING Corp
Entity Central Index Key	1,423,586
Current Fiscal Year End Date	--11-30
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,016
Entity Filer Category	Smaller Reporting Company
Entity Units Outstanding		24,244,876
Entity Public Float			$ 10,946,723
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Nov. 30, 2016	Nov. 30, 2015
Current Assets:
Cash
Total current assets
Total Assets
Current Liabilities:
Accounts payable	5,005	3,905
Due to shareholder	229,997	194,327
Total liabilities	235,002	198,232
Shareholders' Deficit:
Preferred Class A shares - 100,000,000 shares of $ 0.001 par value; issued and outstanding, 750,000	750	750
Common stock: authorized 100,000,000 shares of $0.001 par value; issued and outstanding, 23,818,046	24,245	23,818
Capital in excess of par value	7,646,274	6,793,041
Accumulated deficit	(7,906,271)	(7,015,841)
Total shareholder's deficit	(235,002)	(198,232)
Total Liabilities and Shareholders' Deficit

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Nov. 30, 2016	Nov. 30, 2015
Statement of Financial Position [Abstract]
Preferred Stock, shares authorized	100,000,000	100,000,000
Preferred Stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares issued	750,000	750,000
Preferred stock, shares outstanding	750,000	750,000
Common Stock, shares authorized	100,000,000	100,000,000
Common Stock, par value per share	$ 0.001	$ 0.001
Common Stock, shares issued	23,818,046	23,818,046
Common Stock, shares outstanding	23,818,046	23,818,046

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015
Expenses:
Consulting fees	$ 853,660
Selling and Administrative Expenses	36,770	48,435
Operating loss	(890,430)	(48,435)
Total loss from operations	$ (890,430)	$ (48,435)
Loss Per Share -
Basic and Diluted	$ (0.04)	$ 0
Weighted average number of common shares outstanding	24,130,275	23,818,046

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Nov. 30, 2016	Nov. 30, 2015
CASH FLOWS FROM OPERATIONS:
Net loss	$ (890,430)	$ (48,435)
Adjustments required to reconcile net loss to net cash consumed by operating activities:
Stock based compensation	853,660
Changes in assets and liabilities:
Increase in accounts payable	1,100	(2,935)
Net Cash Consumed by Operating Activities:	(35,670)	(51,370)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from shareholder loans	35,670	51,370
Net Cash Provided by Financing Activities:	35,670	51,370
Net increase (decrease) in cash
Cash balance, beginning of period
Cash balance, end of period

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Nov. 30, 2014	$ 23,818	$ 750	$ 6,793,041	$ (6,967,406)	$ (149,797)
Balance, shares at Nov. 30, 2014	23,818,046	750,000
Net loss for period				(48,435)	(48,435)
Balance at Nov. 30, 2015	$ 23,818	$ 750	6,793,041	(7,015,841)	(198,232)
Balance, shares at Nov. 30, 2015	23,818,046	750,000
Common stock issued for services	$ 427		853,233		853,660
Common stock issued for services, shares	426,830
Net loss for period				(890,430)	(890,430)
Balance at Nov. 30, 2016	$ 24,245	$ 750	$ 7,646,274	$ (7,906,271)	$ (235,002)
Balance, shares at Nov. 30, 2016	24,244,876	750,000

BASIS OF PRESENTATION

BASIS OF PRESENTATION	12 Months Ended
	Nov. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	1. BASIS OF PRESENTATION On July 9, 2015 we merged with our wholly owned Nevada subsidiary, 3 Shine Technologies Inc. As a result of this merger, our corporate name was changed to 3 Shine Technologies, Inc and the trading symbol for our common stock changed to “TSHN.” On September 14, 2015, the Company completed a merger with Rorine International Holding Corporation, a wholly owned subsidiary incorporated in the State of Nevada. This resulted in a corporate name change of the Company to “Rorine International Holding Corporation”. This corporate action was approved by the Company’s Board of Directors as authorized by Nevada corporate law. The corporate name change effected by the merger was effective on October 7, 2015 upon final approval by FINRA which was granted on October 6, 2015. The Company’s trading symbol changed to “RIHC” as a result of the corporate name change The subsidiary was newly formed on September 4, 2015 and merged into the parent public company ten days later on September 14, 2015. The subsidiary had no formal business activities as of November 30, 2015.Selling general and administrative expense consist mainly of professional fees. On January 12, 2016, Rorine International Holding Corporation Inc successfully entered in a marketing and distribution agreement with RICH Group based in South East Asia. The agreement was negotiated and announced by Rorine’s Chief Financial Officer Mr Tan Sew. According to Mr Tan this agreement has taken several months to plan and negotiate and “will give Rorine an excellent opportunity to market Eastern alternative medical packages related to Type II Diabetes outside of China to non-traditional markets such as in the West.” The agreement was signed between Rorine International Holding Corporation and RICH Group who had previously acquired Guangzhou Huanai Nutrition and Health Information Co. Ltd and Guangzhou Tongde Hospital. One of RICH Group’s diversified investment holdings has been in alternative medicine & treatment for Type II Diabetes, specifically in China where roughly 10% of the population is susceptible to it. They have a non-invasive treatment program based on the combination of traditional Chinese medicine and modern hyperthermia, elemental balance therapy, psychotherapy, resulting in complete restoration to normal health and diet. They currently have a separate marketing and distribution company specifically for the China market. This new agreement allows them to move outside of China into new and growing markets specifically targeting western patients. According to this agreement, Rorine will setup and prepare a marketing strategy and platform as well as liaise with hospitals, clinics and associations in order to bring this unique product to markets in the West where Diabetes is also on the rise. The agreement is part of a long term strategy initiated by the Board of Directors of Rorine International Holding Corporation, faithfully guided by its Chief Officer Mr Tesheb Casimir. Part of this turn around occurred when the Board decided to appoint Mr Tan Sew as its CFO in late 2015. Mr Tan has been involved in new project finance and development in South East Asia for the past 20 years. On March 14, 2016, an Amendment to the Company’s Articles of Incorporation was filed with the Nevada Secretary of State which increased the Company’s authorized shares of common stock to 2,000,000,000 shares from 100,000,000 shares. The amendment was approved by owners of 66.96% of the Company’s common stock and by the owner of 100% of the Company’s preferred stock. The amendment was effective upon filing on March 14, 2016. Accounts payable consist of vendor payables at November 30, 2016 and November 30, 2015.

SUPPLEMENTAL CASH FLOWS INFORMA

SUPPLEMENTAL CASH FLOWS INFORMATION	12 Months Ended
	Nov. 30, 2016
Supplemental Cash Flow Elements [Abstract]
SUPPLEMENTAL CASH FLOWS INFORMATION	2. SUPPLEMENTAL CASH FLOWS INFORMATION There was no cash paid for either interest or income taxes during either of the periods presented. There were no non-cash investing or financing activities during either of the periods presented.

GOING CONCERN

GOING CONCERN	12 Months Ended
	Nov. 30, 2016
GOING CONCERN [Abstract]
GOING CONCERN	3. GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the financial statements, the Company has experienced continued losses, has a working capital deficiency of $235,002 has an accumulated deficit of $7,906,271 and does not presently have sufficient resources to accomplish its objectives during the next twelve months. On August 1, 2012, the Company began a new business. The new business enterprise was initiated with the creation of a wholly owned subsidiary, Unwall Technologies Holdings, Sdn. Ghd (Technologies), a Malaysian corporation incorporated on July 12, 2012. The Company plans to introduce applications for mobile devices in the first half of 2013 and web applications later in the year. The Company is considered a development stage entity because this new business enterprise is in the process of platform development and has not derived significant revenue from operations.. In November, 2011, the Company name was changed to Unwall International Inc. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include adjustments relating to the recoverability of assets and classification of liabilities that might be necessary should the Company be unable to continue in operation. The Company’s present plans, the realization of which cannot be assured, are to raise necessary funds through shareholder loans.

CONTINGENCY

CONTINGENCY	12 Months Ended
	Nov. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCY	4. CONTINGENCY The Company does not carry Directors and Officer’s insurance.

SHAREHOLDER LOANS

SHAREHOLDER LOANS	12 Months Ended
	Nov. 30, 2016
Debt Disclosure [Abstract]
SHAREHOLDER LOANS	5. SHAREHOLDER LOANS The shareholder loans are non-interest bearing demand loans and are properly classified on the balance sheet as a current liability.

COMMON STOCK

COMMON STOCK	12 Months Ended
	Nov. 30, 2016
Stockholders' Equity Note [Abstract]
COMMON STOCK	6. COMMON STOCK On August 23, 2016 the Company issued issued 426,830 shares of common stock to a consultant value at $853,660 ($2.00 per share).

PRINCIPLE OF CONSOLIDATION

PRINCIPLE OF CONSOLIDATION	12 Months Ended
	Nov. 30, 2016
PRINCIPLE OF CONSOLIDATION [Abstract]
PRINCIPLE OF CONSOLIDATION	7. PRINCIPLE OF CONSOLIDATION The consolidated financial statements represent the combined results of Rorine International Holdings Corp. and its wholly owned subsidiary, Unwall Technologies Holdings, SdnGhd. All intercompany balances have been eliminated.

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	12 Months Ended
	Nov. 30, 2016
Discontinued Operations and Disposal Groups [Abstract]
DISCONTINUED OPERATIONS	8. DISCONTINUED OPERATIONS The Company began development stage activities through its wholly owned Malaysian subsidiary, Unwall Technologies Holdings, SdnGhd. on September 1, 2012. Operations of the Malaysian subsidiary effectively ceased on May 31, 2013, and closed by August 31, 2013. The equipment and software owned by this subsidiary had no material value and were either abandoned or given to employees. Unwall International has assumed responsibility for any remaining accounts payable of the subsidiary. A planned social lending division was terminated with no viable development before October 31, 2013.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Nov. 30, 2016
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	9. RELATED PARTY TRANSACTIONS As of November 30, 2016 and 2015 the Company Principal Executive Officer had advanced the Company a total of $229,997 and $194,327, respectively.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Nov. 30, 2016
Income Tax Disclosure [Abstract]
INCOME TAXES	10. INCOME TAXES The Company accounts for income taxes under an asset and liability approach. The Company determines whether a tax position is more likely than not to be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The Company files income tax returns in the United States (“U.S.”) Federal and the States of Hawaii and California jurisdictions. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. The Company has experienced net operating losses each year since its inception. The Internal Revenue Code allows net operating losses (NOL's) to be carried forward and applied against future profits for a period of twenty years. Malaysia does not have a limitation on loss carryforwards. The potential benefit of these carryovers has been recognized on the books of the Company, but it has been offset by a valuation allowance. If not used, these NOL's will expire in the U.S. as follows: 2031 $ 17,626 2032 37,664 2033 58,616 2034 35,890 2035 16,952 2036 $ 12,870 Under pronouncements of the FASB, recognition of deferred tax assets is permitted unless it is more likely than not that the assets will not be realized. The Company has recorded deferred tax assets as follows: Tax asset $ 81,111 Valuation Allowance ( 81,111 ) Balance Recognized $ - The valuation allowance changed by $12,870 during the 2016 year. The Internal Revenue Code permits audits by the Internal Revenue Service for periods up to three years from the date tax returns are filed. Malaysia has no stated limitation. Tax returns of the Company are subject to audit for the years ended November 30, 2014, 2015 and 2016.

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Nov. 30, 2016
Income Tax Disclosure [Abstract]
Summary of Net Operating Loss Carryforwards	The Company has experienced net operating losses each year since its inception. The Internal Revenue Code allows net operating losses (NOL's) to be carried forward and applied against future profits for a period of twenty years. Malaysia does not have a limitation on loss carryforwards. The potential benefit of these carryovers has been recognized on the books of the Company, but it has been offset by a valuation allowance. If not used, these NOL's will expire in the U.S. as follows: 2031 $ 17,626 2032 37,664 2033 58,616 2034 35,890 2035 16,952 2036 $ 12,870
Schedule of Deferred Tax Assets	The Company has recorded deferred tax assets as follows: Tax asset $ 81,111 Valuation Allowance ( 81,111 ) Balance Recognized $ -

BASIS OF PRESENTATION (Details)

BASIS OF PRESENTATION (Details) - shares	Nov. 30, 2016	Mar. 14, 2016	Mar. 13, 2016	Nov. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Common Stock, shares authorized	100,000,000	2,000,000,000	100,000,000	100,000,000

GOING CONCERN (Details)

GOING CONCERN (Details) - USD ($)	Nov. 30, 2016	Nov. 30, 2015
GOING CONCERN [Abstract]
Working capital deficit	$ 235,002
Accumulated deficit	$ 7,906,271	$ 7,015,841

COMMON STOCK (Details)

COMMON STOCK (Details)	12 Months Ended
	Nov. 30, 2016USD ($)$ / sharesshares
Class of Stock [Line Items]
Common stock issued for services	$ 853,660
Common Stock [Member]
Class of Stock [Line Items]
Common stock issued for services	$ 427
Common stock issued for services, shares | shares	426,830
Equity issuance price per share | $ / shares	$ 2

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($)	Nov. 30, 2016	Nov. 30, 2015
Related Party Transactions [Abstract]
Due to shareholder	$ 229,997	$ 194,327

INCOME TAXES (Summary of Net Op

INCOME TAXES (Summary of Net Operating Loss Carryforwards) (Details) - Internal Revenue Service (IRS) [Member]	12 Months Ended
	Nov. 30, 2016USD ($)
Operating Loss Carryforward One [Member]
Operating Loss Carryforwards [Line Items]
Expiration date	Dec. 31, 2031
Net operating loss carryforwards	$ 17,626
Operating Loss Carryforward Two [Member]
Operating Loss Carryforwards [Line Items]
Expiration date	Dec. 31, 2032
Net operating loss carryforwards	$ 37,664
Operating Loss Carryforward Three [Member]
Operating Loss Carryforwards [Line Items]
Expiration date	Dec. 31, 2033
Net operating loss carryforwards	$ 58,616
Operating Loss Carryforwards Four [Member]
Operating Loss Carryforwards [Line Items]
Expiration date	Dec. 31, 2034
Net operating loss carryforwards	$ 35,890
Operating Loss Carryforward Five [Member]
Operating Loss Carryforwards [Line Items]
Expiration date	Dec. 31, 2035
Net operating loss carryforwards	$ 16,952
Operating Loss Carryforward Six [Member]
Operating Loss Carryforwards [Line Items]
Expiration date	Dec. 31, 2036
Net operating loss carryforwards	$ 12,870

INCOME TAXES (Schedule of Defer

INCOME TAXES (Schedule of Deferred Tax Assets) (Details)	Nov. 30, 2016USD ($)
Income Tax Disclosure [Abstract]
Tax asset	$ 81,111
Valuation Allowance	(81,111)
Deferred income taxes

INCOME TAXES (Narrative) (Detai

INCOME TAXES (Narrative) (Details)	12 Months Ended
	Nov. 30, 2016USD ($)
Income Tax Disclosure [Abstract]
Change in valuation allowance during the period	$ 12,870